Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial.

Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial.

अन्य संस्करण दिखाएं (1)

BACKGROUND: Chronic kidney disease is associated with increased arterial stiffness even in the early stages and this is thought to be a key mediator in the pathophysiology of the increased cardiovascular risk associated with this condition. The use of low-dose spironolactone has previously been show...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Ng, K, Jain, P, Heer, G, Redman, V, Chagoury, O, Dowswell, G, Greenfield, S, Freemantle, N, Townend, J, Gill, P, McManus, R, Ferro, C
स्वरूप: Journal article
भाषा:English
प्रकाशित: 2014

समान संसाधन